Physical activity, body mass index, and cardiovascular biomarkers in women.

H. Cheng

DOI: https://doi.org/10.1001/JAMA.296.8.931-B

2006-08-23

Abstract:

What problem does this paper attempt to address?

Long-term Outcome of Correction of Tetralogy of Fallot in 56 Adult Patients.

Zheng Da-wei,Shao Guo-feng,Feng Qiang,Ni Yi-ming

DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20130384

IF: 6.133

2013-01-01

Chinese Medical Journal

Abstract:BACKGROUND:Although most patients with tetralogy of Fallot undergo radical repair during infancy and childhood, patients that remain undiagnosed and untreated until adulthood can still be treated. This study aimed to evaluate longterm outcomes of adult patients with tetralogy of Fallot who were treated surgically, and to determine the predictors of postoperative pulmonary regurgitation.METHODS:Fifty-six adult patients underwent complete surgical repair. Forty-three patients (76.8%) required a transannular patch. Systolic, diastolic, and mean pressure in the main pulmonary artery were measured after repair.RESULTS:The early mortality rate was 3.6%. The 16-year survival rate was (84.4 ± 11.5)%. Late echocardiography revealed 41 patients with transannular patch who had pulmonary regurgitation, consisting of mild pulmonary regurgitation in 28 patients, moderate in eight, and severe regurgitation in five patients. In addition, there was right ventricular outflow tract stenosis in nine patients, moderate/severe tricuspid valve regurgitation in seven, and residual ventricular septal defect in five. Logistic regression analysis demonstrated that the mean pulmonary pressure measured just after repair predicted late pulmonary regurgitation.CONCLUSIONS:The long-term survival of surgically treated adult patients with tetralogy of Fallot is acceptable. The mean pressure >20 mmHg in the main pulmonary artery measured right after surgical repair may be a feasible reference to time the reconstruction of the pulmonary valve.
Pupillary Response to Value-Linked Words

R. Vacchiano,P. Strauss,Sharon Ryan,L. Hochman

DOI: https://doi.org/10.2466/pms.1968.27.1.207

1968-08-01

Perceptual and Motor Skills

Abstract:Pupillary measurements were taken on 12 Ss who viewed sequences of words reflecting values of high, low, and neutral importance to them. No significant relationships were found between most measures of pupil size and word value. Changes in pupil size between word pairs of different value were evenly divided between constrictions and dilations according to chance. This lack of supporting evidence for current theories of pupillometrics is discussed in terms of experimental research problems.
Pulmonary Valve Replacement in Primary Repair of Tetralogy of Fallot in Adult Patients

Huan Liu,Shun Liu,Anthony Zaki,Xiuwen Wang,Kai Zhu,Yuntao Lu,Ye Yang,Rafi Hamidi,Lai Wei,Chunsheng Wang

DOI: https://doi.org/10.21037/jtd-20-1475

2020-01-01

Journal of Thoracic Disease

Abstract:Background Adults with unrepaired tetralogy of Fallot (ToF) are common in developing countries. Long-term overload of the right ventricle places adult patients at risk for postoperative right heart failure after primary repair, which contributes to morbidity and mortality. The effect of pulmonary valve replacement (PVR) in reducing postoperative morbidity and mortality in adults has never been validated. Methods We conducted a retrospective cohort study in adults (age ≥18 years) with ToF undergoing primary repair from January 2014 to December 2019 at our institution. Patients were divided into three groups according to techniques used to enlarge the right ventricle outflow tract (RVOT). Baseline variables and perioperative outcomes were collected. The primary endpoint was operative mortality. Secondary endpoints were incidences of right heart failure and stage 3 acute kidney injury (AKI). Results A total of 56 patients were enrolled (mean age 41.5±11.7 years, 30 females, 53.6%). They were divided into three groups designated as the following: TA-PVR group for trans-annular patch enlargement with PVR; TA group for trans-annulus patch enlargement without PVR; and group AP for annulus preservation. Four patients (7.1%) died postoperatively, all due to right heart failure. All twelve patients in the TA-PVR group survived. There was no significant difference in mortalities among groups. Ten patients (17.9%) developed right heart failure after surgery with no significant difference among groups. Three patients (5.4%) developed stage 3 AKI after surgery, none belonging to the TA-PVR group, however, not statistically significant. Conclusions Right heart failure is a common complication after primary repair of adult ToF. Trans-annulus patch enlargement should be cautiously selected in this population. PVR with trans-annulus patch enlargement may be a promising technique to protect against postoperative right heart failure and mortality when annulus preservation is not feasible.
[Interventional Treatment and Early-Stage Follow-Up of Pulmonary Atresia with Intact Ventricular Septum].

Y J Wang,S L Fu,W Wang,J Hu,Y Q Qi,L C Gao,Q Zhang,C H Xie,Y,F Q Gong

DOI: https://doi.org/10.3760/cma.j.cn112140-20221029-00919

2023-01-01

Abstract:Objective: To explore the application value of percutaneous peripheral interventional therapy in pulmonary atresia with intact ventricular septal (PA-IVS). Methods: Retrospective case summary. The data was collected from 25 children who were hospitalized at the Children's Hospital,Zhejiang University School of Medicine from August 2019 to August 2022, had been diagnosed with PA-IVS by echocardiography, and underwent interventional treatment. The sex, age, weight, operation time, radiation exposure time, and radiation dose of the patients were collected. The patients were divided into the arterial duct stenting group and the non-stenting group. Preoperative tricuspid annular diameters and Z scores, right ventricular length diameters, and right ventricular/left ventricular length-diameter ratios were compared by paired t-tests. Right ventricular systolic pressure difference, oxygen saturation, lactic acid before and after the surgery were compared for 24 children who received percutaneous balloon pulmonary valvuloplasty. Right ventricular improvement in 25 children after operation was analyzed. The correlation between postoperative oxygen saturation and postoperative right ventricular systolic blood pressure difference, the degree of pulmonary valve opening and the Z value of tricuspid valve ring in the non-stenting group were analyzed. Results: A total of 25 patients with PA-IVS were enrolled in the study, of whom 19 were males and 6 females, with an age at surgery of 12 (6, 28) days and a weight of (3.7±0.5) kg. One of them underwent only stenting of the arterial duct; 20 children underwent only percutaneous pulmonary valve perforation and balloon angioplasty; 4 children underwent both procedures. The Z-value of the tricuspid ring was -1.5±1.2 in the group with arterial duct stenting, and -0.1±0.4 in the group without stenting (t=2.77, P=0.010). The tricuspid regurgitant flow rate 1 month after surgery was significantly lower than the preoperative ((3.4±0.6) vs. (4.8±0.9) m/s, t=6.62,P<0.001). In the 24 children with percutaneous pulmonary valve perforation and balloon angioplasty, the preoperative right ventricular systolic blood pressure was (110±32) mmHg, and the postoperative systolic blood pressure was (52±19) mmHg (1 mmHg=0.133 kPa) (F=59.55, P<0.001). The factors that may affect postoperative oxygen saturation in 20 cases of non-stenting group were analyzed. The results suggested that the pre and post-operative right ventricular systolic blood pressure differences (r=-0.11, P=0.649), and the pulmonary valve orifice opening (r=-0.31, P=0.201) and tricuspid annulus Z value (r=-0.18, P=0.452) at 1 month after the operation were not significantly correlated with the postoperative oxygen saturation. Conclusions: Interventional therapy can be used as the first choice for one-stage operation of PA-IVS. Percutaneous pulmonary valve perforation and balloon angioplasty are more suitable for children with well-developed right ventricles, tricuspid annulus, and pulmonary arteries. While the smaller the tricuspid annulus, the more dependent it is on the ductus arteriosus and thus patients are more suitable for arterial duct stenting.
Surgical anatomy of the rat facial nerve.

Mattox De,H. Felix

Abstract:Animal models of facial nerve healing and regeneration are becoming increasingly important as new techniques of facial nerve repair and grafting are developed. We have described in detail the peripheral branching pattern of the rat facial nerve and performed axon counts on the main trunk and peripheral branches. Similarities and differences between the human and rat facial nerve are emphasized and the branches of the rat nerve amenable to experimental manipulation are identified. In addition, electrophysiologic data from the rat show a more diffuse pattern of innervation of the face from the individual branches than seen in humans.
Primary transcatheter dilation of the pulmonary valve in cyanotic patients with tetralogy of Fallot and dominant pulmonary valve stenosis

Nathalie Mini,Claudia Arenz,Marian Mikus,Martin B. E. Schneider

DOI: https://doi.org/10.3389/fcvm.2024.1489413

IF: 3.6

2024-11-17

Frontiers in Cardiovascular Medicine

Abstract:Objectives: This study reviews the outcome of pulmonary valve dilation (PVB) in patients with tetralogy of Fallot (TOF) and predominantly pulmonary valve stenosis as first palliation and the impact of balloon-related cusp tears (BRCTs) on the surgical strategy. Background: The early management of cyanotic patients TOF is still controversial. Methods: This was a retrospective study of 19 patients with TOF who underwent PVB over 4 years. Differential growth of the pulmonary valve/annulus (PV) and arteries was documented, as was differential saturation improvement. Surgical findings were analyzed, including BRCT and subsequent surgical methods. Results: The median saturation value improved significantly from 70% (45%–98%) to 90% (74%–98%) ( p -value = 0.03). Recurrent desaturation 7–45 days after the intervention occurred in 7 patients; 2 needed reinterventions, and 5 needed an early repair. At the time of repair, the median PV z-score improved from −3.7 (−6.12 to −1.3) to −2.1 (−4.2 to −0.19) ( p -value = 0.2). The LPA z-score improved from −1.95 (−3.4 to −0.4) to 0.36 (−2.9 to 1.8) ( p -value = 0.2), and the RPA z-score improved from −2 (−2.8 to 0.04) to 0.18 (−2.4 to 1.3) ( p -value = 0.34). The mean pressure gradient decreased from 50 mmHg (32–72) to 38 mmHg (20–55) ( p -value 0.08). The surgical repair was on time in 13 patients; one was still waiting for surgery. BRCTs were found in 8 patients and had no impact on the surgical strategy. Seven patients needed transannular patching, and in 11, the PV could be preserved (including 7 with BRCTs). Conclusion: Palliative transcatheter dilation of predominantly pulmonary valve stenosis in patients with TOF and predominantly pulmonary valve stenosis is safe and effective in palliating cyanosis in most patients. It can improve saturation and prompt pulmonary development, delaying the surgical repair to the right time. A subsequent BRCT seems to have no negative impact on the surgical strategy.

cardiac & cardiovascular systems
The best way to prevent cytomegalovirus infection after liver transplantation: the debate goes on

H. Metselaar,M. Campenhout,A. A. Eijk

DOI: https://doi.org/10.1111/tri.12108

2013-06-01

Transplant International

Abstract:Cytomegalovirus (CMV) infection is an opportunistic infection frequently found in liver transplant recipients, especially in CMV-seronegative recipients of grafts from CMV-seropositive donors (D+/R ). In these high-risk patients, CMV infection can become clinically apparent with a mononucleosis-like syndrome, hepatitis, gastrointestinal ulceration and pneumonia [1]. In the past, when specific therapy and rapid diagnostic tools were lacking, CMV disease, which can be classified into infection with organ involvement (tissue invasive CMV disease) and without organ involvement (CMV syndrome), was associated with high mortality. However, this has changed dramatically with the introduction of specific virostatics and improved diagnostics. The availability of (val)ganciclovir (VGC) and realtime RT-PCR to quantify CMV DNA enabled the clinician to interfere in a preclinical phase of disease development. These so-called prevention strategies can be divided in prophylaxis and preemptive therapy with antiviral medication. The recommended agents and dose for prophylaxis are VGC 900 mg or ganciclovir 5 mg/kg once daily for at least 3 months after transplantation, whereas in preemptive therapy, patients are closely monitored and given VGC 900 mg or ganciclovir 5 mg/kg twice daily whenever CMV viremia is detected [2]. A recent update of a Cochrane review first published in 2005 stated that both strategies were effective in reducing the risk of CMV disease. However, the efficacy of preemptive therapy compared with prophylaxis to prevent CMV disease remains unclear because of significant heterogeneity between studies. Additional head to head studies are required to determine the risks and benefits of either strategy to prevent CMV disease in solid organ transplant recipients [3]. A recent international survey of cytomegalovirus management practices showed that prophylaxis is the most commonly used preventive strategy, but significant variation exists in the way it is implemented. Specifically, duration of prophylaxis is extremely variable [4]. A study comparing 100 vs. 200 days of VGC prophylaxis showed a significantly lower incidence of CMV disease in the longer treated patient group [5]. This finding suggests that prophylaxis should be longer than the first 100 days after transplantation. An argument in favour of the prophylactic strategy is a recent French publication showing that preemptive therapy is associated with a higher virostatic drug
The impact of tricuspid regurgitation on the timing of pulmonary valve replacement in adult patients after Tetralogy of Fallot repair

G Brancaccio,D Fugallo,M Trezzi,V Bordonaro,A Secinaro,E Piccinelli,F Miraldi,G Butera,M Chinali,V Lisignoli,R Iacobelli,B Leonardi,F Iodice,L Galletti

DOI: https://doi.org/10.1093/eurheartj/ehae666.2137

IF: 39.3

2024-10-29

European Heart Journal

Abstract:Background Tricuspid regurgitation (TR) in patients with repaired tetralogy of Fallot (rTOF) is an important finding with a wide spectrum of etiologies. TR represents an important risk factor in adult patients with rTOF, influencing clinical outcomes and the requirement for additional surgical interventions. In this study, we reviewed the long-term outcomes of TR in ACHD patients with rTOF as well as its impact on the timing of surgical pulmonary valve replacement (PVR). Methods This was a retrospective analysis of a single institutional cohort which included 149 ACHD patients with a history of rTOF (transannular patch only) with CMR data, complete follow-up, and a recent (< 1 year) outpatient clinic visit. Results Overall follow-up time was 25.5 years (95% CI 24.5,26.4). Between 2002 and 2021, 93 patients required isolated PVR at a mean time from TOF repair of 16.6 years (95% CI 15.5,17.7) and at a mean age of 17.9 years (95% CI 16.8,19.0). In the whole cohort, significant TR was associated with a two-fold increase in the likelihood of requiring PVR (log-rank p = 0-.0023, HR 2.02; 1.09-4-47). Moderate to severe TR was more frequent in those who underwent VSD closure through a right atriotomy (17 versus 0, p = .0002) and affected time to PVR (13.9 versus 16.3 years, p = .0071), with equal preoperative RVEDVi at CMR. After PVR, RVEDVi normalized in all patients, regardless of the preoperative amount of TR (median 115.3 ml/m2 versus 112.3 ml/m2, p = .7). At a median time of 6.5 years from PVR, 13 patients (13/93, 14%) underwent redo PVR. Conclusions The preoperative severity of tricuspid regurgitation (TR) may have a substantial role on the likelihood of patients needing PVR at a younger age. This, in turn, could result in a reduced duration of freedom from valve failure. Replacing the pulmonary valve too early can effectively increase the lifetime number of procedures, preserving the function of the tricuspid valve at the time of TOF repair is of paramount importance.

cardiac & cardiovascular systems
Surgical Strategies for Preservation of Pulmonary Valve Function in a Radical Operation for Tetralogy of Fallot: A Systematic Review and Meta-Analysis

Kang Yi,Dan Wang,Jianguo Xu,Xin Zhang,Wenxin Wang,Jie Gao,Wei Wang,Tao You,Jinhui Tian

DOI: https://doi.org/10.3389/fcvm.2022.888258

IF: 3.6

2022-07-13

Frontiers in Cardiovascular Medicine

Abstract:Objective: To evaluate the efficacy and safety of different surgical strategies to preserve pulmonary valve function. Surgical procedures evaluated include intraoperative balloon pulmonary valvuloplasty (IBPV), pulmonary valve reconstruction, and commissurotomy and pulmonary cusp augmentation (PCA) in patients who underwent a radical operation for Tetralogy of Fallot (ToF). Materials and Methods: The five databases searched in the current study included the Cochrane Library, PubMed, China National Knowledge Infrastructure, VIP, and WanFang data. A systematic search for control trials was performed in each database from the start date of each database until December 2021. The Newcastle-Ottawa Scale (NOS) was used to evaluate the quality of included studies. Results: A total of 15 retrospective studies with a total number of 1,396 participants were included in this study. In subgroup 1 (IBPV vs. TAP), patients undergoing IBPV had a less degree of regurgitation at 1–2 years after the surgery. The reintervention rate increased in the IBPV group at 5 years. In subgroup 2 (pulmonary valve reconstruction vs. TAP), the degree of regurgitation decreased in the pulmonary valve reconstruction group at 1 month after the surgery. In subgroup 3 (valve-sparing operation vs. TAP), the comparison demonstrated decreased rates for surgical mortality and reintervention at 5–10 years after the surgery. Conclusion: We proposed that pulmonary valve function in a radical operation for ToF was preserved. IBPV, pulmonary valve reconstruction, and commissurotomy and PCA can be performed during the surgical procedure based on the developmental status and anatomical characteristics of the right ventricular outflow tract (RVOT), pulmonary valve, and pulmonary artery. Systematic Review Registration: [https://www.crd.york.ac.uk/prospero/], identifier [CRD42022300987].

cardiac & cardiovascular systems
Long-term behavior of radiosodium in bone: Comparison with radiocalcium and effects of various procedures

G. Forbes,A. Mccoord

DOI: https://doi.org/10.1007/BF02279113

Calcified Tissue Research

Abstract:
Transcatheter Tricuspid and Pulmonary Valve Repair and Replacement

Christopher M Faries,Aditya Sengupta,Sophia L Alexis,Rami O Tadros,David Octeau,Hanna J Barnes,Gilbert H L Tang

2020-05-28

Abstract:Severe tricuspid regurgitation (TR) is associated with significant mortality and morbidities. Currently, surgical tricuspid repair with annuloplasty is the gold standard treatment. However, the prohibitive risks of open surgery and increasing evidence that severe TR should be intervened on early has led to an outburst in the development and evolution of transcatheter tricuspid valve interventions (TTVI). These technologies are broadly categorized into direct suture annuloplasty devices, minimally invasive annuloplasty, direct ring annuloplasty devices, coaptation-based strategies, edge-to-edge repair devices, and transcatheter valve replacement. Each has its own set of advantages and limitations and have been tried, to varying degrees of success, in a myriad of pathoanatomic scenarios. Challenges faced in TTVI device and trial designs include heterogeneous patient populations, the need for quality imaging, variations of imaging requirements and anatomic criteria by device, hard-to-define clinical endpoints, and the poor prognosis carried by significant residual TR. Similar to tricuspid valve disease, pulmonic valve (PV) disease can occur on its own or secondary to a congenital heart defect, most commonly tetralogy of Fallot. Many patients with pulmonic stenosis or insufficiency often require repeat surgical interventions for other cardiac problems, highlighting the importance of developing transcatheter approaches to reduce the number of repeat open-heart surgeries required. Transcatheter PV replacement (TPVR) is growing in use and is the procedure of choice in patients with failed bioprostheses via valve-in-valve implantation. The Melody (Medtronic Inc., Minneapolis, Minnesota) and SAPIEN XT (Edwards Lifesciences Inc., Irvine, California) devices are the currently available TPVR technologies. Current limitations here include device kinking, the risk of stent fracture, anatomic difficulties, such as asymmetric right ventricular outflow tracts leading to poor landing zones and procedural risks of coronary artery and aortic root compression.
Have We Understood the Right Timing of PVR?

Benedetta Leonardi,Marco Perrone,Giuseppe Calcaterra,Jolanda Sabatino,Isabella Leo,Martina Aversani,Pier Paolo Bassareo,Alice Pozza,Lilia Oreto,Sara Moscatelli,Nunzia Borrelli,Francesco Bianco,Di Salvo Di Salvo

DOI: https://doi.org/10.3390/jcm13092682

IF: 3.9

2024-05-03

Journal of Clinical Medicine

Abstract:Despite many advances in surgical repair during the past few decades, the majority of tetralogy of Fallot patients continue to experience residual hemodynamic and electrophysiological abnormalities. The actual issue, which has yet to be solved, is understanding how this disease evolves in each individual patient and, as a result, who is truly at risk of sudden death, as well as the proper timing of pulmonary valve replacement (PVR). Our responsibility should be to select the most appropriate time for each patient, going above and beyond imaging criteria used up to now to make such a clinically crucial decision. Despite several studies on timing, indications, procedures, and outcomes of PVR, there is still much uncertainty about whether PVR reduces arrhythmia burden or improves survival in these patients and how to appropriately manage this population. This review summarizes the most recent research on the evolution of repaired tetralogy of Fallot (from adolescence onwards) and risk factor variables that may favor or delay PVR.

medicine, general & internal
Editorial Comment to Clinical outcome analysis of male and female genital burn injuries: A 15‐year experience at a Level‐1 Burn Center

D. Michielsen,K. Van Bael

DOI: https://doi.org/10.1111/j.1442-2042.2012.02985.x

2012-04-01

International Journal of Urology

Abstract:genital burns are a rare event and typically occur in patients suffering extensive TBSA burns. When presented with a genital burn patient, clinicians should counsel the patient regarding an extended hospital stay and increased rate of morbidity secondary to the extensive TBSA burns commonly associated with genital burns. Most patients with genital burns can initially be treated conservatively, with STSG and surgical debridement carried out later during the hospital stay and usually in the context of extensive TBSA burns. These patients are best managed at a Level-1 burn center equipped with fellowship-trained burn and critical care specialists because of the patient’s extensive multisystem injuries, prolonged hospital stay and increased morbidity and mortality.
Transcatheter pulmonary valve replacement in surgically‐created double‐barrel right ventricular outflow tracts: A single center case‐series

Nicholas Seizo Boscamp,Nicola Maschietto,Diego Porras

DOI: https://doi.org/10.1002/ccd.30954

IF: 2.3

2024-01-12

Catheterization and Cardiovascular Interventions

Abstract:This manuscript describes the feasibility and approach to the assessment and performance of transcatheter pulmonary valve replacement (tPVR) in patients with surgically‐created "double‐barrel" right ventricular outflow tracts (RVOT). Patients with tetralogy of Fallot may have coronary anomalies which prohibit the performance of traditional tetralogy of Fallot repair. In certain cases, this may necessitate the placement of a right ventricle to pulmonary artery conduit in addition to the native RVOT, which is left in situ, creating so‐called "double‐barrel" RVOTs. When these patients develop RVOT dysfunction later in life, they would typically be referred for reoperation due to concerns for risk of coronary compression associated with a transcatheter approach. However, whether a transcatheter approach with valve replacement in the native RVOT is feasible or safe is unknown. This was a retrospective review of patients with a surgically created "double‐barrel" RVOTs who underwent cardiac catheterization for assessment of tPVR at Boston Children's Hospital. From July 2012 to July 2022, there were four patients with "double‐barrel" RVOTs who underwent assessment for tPVR. The age at catheterization ranged between 22 and 39 years. In three out of four patients, coronary compression testing was negative. These three patients had successful tPVR in the native RVOT. At follow up, all three patients were free of greater than mild regurgitation by echocardiogram and had a maximum instantaneous gradient across the RVOT ranging between 20 and 33 mmHg. Performance of tPVR in patients with surgically created "double‐barrel" RVOTs is feasible. The safety of this procedure depends crucially on coronary artery assessment at all stages.

cardiac & cardiovascular systems
Long-term Outcomes of Tetralogy of Fallot Repair: A 30-year experience with 960 patients

Shuta Ishigami,Xin Tao Ye,Edward Buratto,Yaroslav Ivanov,Kuntal Roy Chowdhuri,Nick Fulkoski,Terry Robertson,Ben Davies,Christian P. Brizard,Igor E. Konstantinov

DOI: https://doi.org/10.1016/j.jtcvs.2023.04.015

IF: 6.439

2023-05-11

Journal of Thoracic and Cardiovascular Surgery

Abstract:Objective This study is to evaluate the long-term results of TOF repair and assess the risk factors for adverse outcomes. Methods This retrospective study involved 960 patients who underwent trans-atrial trans-pulmonary TOF repair between 1990 and 2020. Results Trans-annular patch (TAP) was placed in 722 patients and pulmonary valve preservation (PVP) was achieved in 233 patients. The median age at TOF repair was 9.4 (IQR, 6.2-14.2) months. The median follow-up duration was 10.6 (IQR, 5.4-16.3) years. There were 8 early deaths (0.8%) and 20 late deaths (2.1%). Genetic syndrome and pulmonary valve annulus Z score < -3 were risk factors for mortality. The survival rate was 97.7 % [95% CI: 96.4-98.5] and 94.5% [95% CI: 90.9-96.7] at 10 and 30 years, respectively. Freedom from any reoperation was 86.4% [95% CI: 83.6-88.7.] and 65.4% [95% CI:59.8-70.4] at 10 and 20 years. Post-operative right ventricular outflow tract (RVOT) peak gradient ≥ 25mmHg correlated with reoperation. Propensity score matched analysis demonstrated that freedom from pulmonary valve replacement (PVR) at 15 years was higher in patient with PVP compared to those with TAP (98.2% vs 78.4%, p = 0.004). Freedom form reoperation for RVOT obstruction at 15 years was lower in PVP group compared to TAP group (p = 0.006). Conclusions The long-term outcomes of TOF repair are excellent. A post-operative RVOT peak gradient less than 25 mmHg appears to be optimal to prevent reoperation. If pulmonary valve size is suitable, PVP reduced the risk of PVR, yet increased reoperation rate for RVOT obstruction.

surgery,cardiac & cardiovascular systems,respiratory system
Current Strategy of Repair of Tetralogy of Fallot in Children and Adults: Emphasis on a New Technique to Create a Monocusp‐Patch for Reconstruction of the Right Ventricular Outflow Tract

Guo-Wei He,Guo‐Wei He

DOI: https://doi.org/10.1111/j.1540-8191.2008.00700.x

IF: 1.778

2008-10-27

Journal of Cardiac Surgery

Abstract:OBJECTIVES: In older children (>four years) and adults the strategy of repair of tetralogy of Fallot (TOF) should have a low rate of transannular patch to avoid pulmonary insufficiency (PI), and in addition, we developed a new method of reconstruction of the right ventricular outflow tract (RVOT) to reduce PI.METHODS: From 2001 through 2005, 74 patients (50 male, 24 female; mean age of 13.6 +/- 0.8 years, ranging from four to 34 years) with TOF (67) or double outlet RV (DORV)-type-TOF (seven) underwent complete repair. The resection of RVOT stenosis +/- pulmonary valvotomy was principally through RA. A new two-patch technique to create a folded mono-cusp valve by using autologous pericardium was applied since August 2004.RESULTS: The repair was through RA in 52 patients and through RA + RVOT/PA in 22 patients (18/4). TAPR was performed in 17 patients (23%, eight non-valved and nine valved). The aortic cross-clamp time was 130.1 +/- 6.8 min in TAPR group and 85.8 +/- 4.6 min in non-TAPR group (p < 0.0001). The operative mortality was 4.0% (3/74) in all and 2.9% (2/67) in TOF patients (due to low output, uncontrollable bleeding, and repeated bleeding from the pulmonary collateral vessels late) and was similar in TAPR or non-TAPR. The valved patch-repaired patients had mild PI and good RV function postoperatively up to eight to 12 months.CONCLUSIONS: Repair of TOF in older children/adults should include low rate of TAPR of RVOT. If indicated, the new folded monocusp-patch technique is recommended. It is an effective and simple way to markedly reduce postoperative PI with no additional cost.

surgery,cardiac & cardiovascular systems
[Surgical results of tetralogy of Fallot repair with pulmonary valve preservation techniques]

Alvise Guariento,Claudia Cattapan,Francesco Galliotto,Gabriella Ricciardi,Martina Avesani,Biagio Castaldi,Giovanni Di Salvo,Vladimiro L Vida

DOI: https://doi.org/10.1714/4352.43393

Abstract:Background: The long-term complications arising from chronic pulmonary insufficiency after surgical correction of tetralogy of Fallot (TOF) are well documented. In our center, innovative techniques for pulmonary valve (PV) preservation have been adopted and developed for over 10 years. Methods: All patients with TOF and PV stenosis who underwent surgery at our center between January 2008 and December 2022 were included in this study. Patients were evaluated using echocardiography during follow-up, comparing those who underwent classic surgery with transannular patch (TAP) placement and those who underwent PV preservation techniques. Results: Of the 134 patients, 99 (73.9%) were successfully treated using PV preservation techniques. At the time of surgery, the median age was 4.3 months (interquartile range [IQR] 3.4-5.9 months). The median preoperative PV z-score was -2.87 (IQR -3.61;-2.48). The median follow-up time from surgery was 6.6 years (IQR 3.5-8.4 years). During the median follow-up, the right ventricular area change fraction was 47% (IQR 43-50%) in patients treated with PV preservation and 43% (IQR 41-47%) in the TAP group (p=0.005). These data were associated with better PV function in patients treated with preservation. Specifically, insufficiency was mild in 12%, moderate in 35%, and severe in 53% of patients in the TAP group. Conversely, insufficiency was mild in 53%, moderate in 35%, and severe in 11% of patients treated with preservation (p<0.001). Conclusions: Annular integrity and PV function can be preserved during early TOF correction. PV preservation can prevent the long-term development of pulmonary insufficiency and right ventricular dysfunction.
Pulmonary valve replacement—A 10-year single-center surgical experience in ACHD patients

Armin Darius Peivandi,Sven Martens,Anaïs Gion,Andreas Rukosujew,Sabrina Martens

DOI: https://doi.org/10.1371/journal.pone.0310700

IF: 3.7

2024-10-05

PLoS ONE

Abstract:Large-scale analyses of surgical outcomes after surgical pulmonary valve replacement (sPVR) as part of re-do surgery in adults with congenital heart disease (ACHD) are rare. Therefore, we present our outcomes of sPVR in ACHD patients over the last decade and demonstrate our standardized surgical approach. All ACHD patients who underwent sPVR between January 2013 and August 2022 were included. Primary diagnoses, peri-operative data, post-operative echocardiography, pre- and post-operative RV MRI and in-hospital mortality were examined. Pre- and postoperative MRI parameters were compared using paired testing. Standardized surgery was documented. Normality of continuous variables was tested using Shapiro-Wilk test. 79 patients (male 59.5% (n = 47), 71 re-operations (89.9%)) at a median age of 41.7 (52.2–28.8) years were included. Main underlying disease was Tetralogy of Fallot (TOF; n = 47, 59.5%). After removal of degenerated valve/conduit parts, right ventricular outflow tract (RVOT) patch augmentation and implantation of a larger stented bioprosthesis (25mm in 78.5%) were conducted. In 57% of cases, concomitant surgery was performed (mainly tricuspid valve surgery: n = 28, 35.4%). 25 patients (31.6%) were operated with beating heart technique. Echocardiographic outcomes showed no moderate or severe insufficiency (median V max of 2 m/s (2.3–1.77 m/s)) upon discharge. Available MRI data showed significantly lower indexed RV-EDV (p = 0.0006) and RV-ESV (P = 0.0017) after surgery. In-hospital mortality was 5.1% (n = 4). SPVR is a safe therapeutic option with low surgical risk and satisfying post-operative results. It can serve as a solid therapeutic option for patients who need future valve-in-valve interventions.

multidisciplinary sciences
Effect of Somatostatin in the Syrian Hamster Bearing a Transplantable Islet-Cell Tumor*

A. Luyckx **,P. Lefèbvre

DOI: https://doi.org/10.1055/s-0028-1093453

1978-03-01

Abstract:The influence of somatostatin (SRIF) on blood glucose, plasma insulin and plasma glucagon was studied in hamsters bearing a transplantable islet-cell tumor secreting insulin and glucagon as well as in normal controls. Fed anesthetized animals were infused intraperitoneally either at a dose of 10 microgram in 15 min or of 150 microgram in 30 min, and intravenously at a dose of 250 microgram in 30 min. Blood was withdrawn from the jugular vein before and after infusion. Before the infusions, tumor bearing animals (TB) had lower blood glucose, markedly elevated plasma glucagon and slightly lower plasma insulin by comparison with normal hamsters (N). Both doses of somatostatin infused by the intraperitoneal route produced a slight but significant hypoglycemia in TB hamsters but not in normals. Ten microgram SRIF did not affect insulin and plasma glucagon levels whereas 150 microgram SRIF significantly depressed plasma insulin in both types of hamsters (N and TB). This latter dose of SRIF decreased plasma glucagon in normal but not in tumor-bearing hamsters. Intravenous infusion of 250 microgram SRIF did not reduce the hyperglucagonemia of TB hamsters either. These results indicate that somatostatin does not reduce the hyperglucagonemia due to the transplantable islet-cell tumor but nevertheless decreases blood glucose and plasma insulin.
The Role of Cardiopulmonary Exercise Testing for Decision Making in Patients with Repaired Tetralogy of Fallot

Frederic Dallaire,Rachel M. Wald,Ariane Marelli

DOI: https://doi.org/10.1007/s00246-017-1656-z

2017-06-16

Pediatric Cardiology

Abstract:Tetralogy of Fallot is the most common form of cyanotic congenital heart disease. As a result of the surgical strategies employed at the time of initial repair, chronic pulmonary regurgitation (PR) is prevalent in this population. Despite sustained research efforts, patient selection and timing of pulmonary valve replacement (PVR) to address PR in young asymptomatic patients with repaired tetralogy of Fallot (rToF) remain a fundamental but as yet unanswered question in the field of congenital heart disease. The ability of the heart to compensate for the chronic volume overload imposed by PR is critical in the evaluation of the risks and benefits of PVR. The difficulty in clarifying the functional impact of PR on the cardiovascular capacity may be in part responsible for the uncertainty surrounding the timing of PVR. Cardiopulmonary exercise testing (CPET) may be used to assess abnormal cardiovascular response to increased physiologic demands. However, its use as a tool for risk stratification in asymptomatic adolescents and young adults with rToF is still ill-defined. In this paper, we review the role of CPET as a potentially valuable adjunct to current risk stratification strategies with a focus on asymptomatic rToF adolescents and young adults being considered for PVR. The role of maximal and submaximal exercise measurements to identify young patients with a decreased or borderline low peak VO2 resulting from impaired ventricular function is explored. Current knowledge gaps and research perspectives are highlighted.

pediatrics,cardiac & cardiovascular systems

Physical activity, body mass index, and cardiovascular biomarkers in women.

Long-term Outcome of Correction of Tetralogy of Fallot in 56 Adult Patients.

Pupillary Response to Value-Linked Words

Pulmonary Valve Replacement in Primary Repair of Tetralogy of Fallot in Adult Patients

[Interventional Treatment and Early-Stage Follow-Up of Pulmonary Atresia with Intact Ventricular Septum].

Surgical anatomy of the rat facial nerve.

Primary transcatheter dilation of the pulmonary valve in cyanotic patients with tetralogy of Fallot and dominant pulmonary valve stenosis

The best way to prevent cytomegalovirus infection after liver transplantation: the debate goes on

The impact of tricuspid regurgitation on the timing of pulmonary valve replacement in adult patients after Tetralogy of Fallot repair

Surgical Strategies for Preservation of Pulmonary Valve Function in a Radical Operation for Tetralogy of Fallot: A Systematic Review and Meta-Analysis

Long-term behavior of radiosodium in bone: Comparison with radiocalcium and effects of various procedures

Transcatheter Tricuspid and Pulmonary Valve Repair and Replacement

Have We Understood the Right Timing of PVR?

Editorial Comment to Clinical outcome analysis of male and female genital burn injuries: A 15‐year experience at a Level‐1 Burn Center

Transcatheter pulmonary valve replacement in surgically‐created double‐barrel right ventricular outflow tracts: A single center case‐series

Long-term Outcomes of Tetralogy of Fallot Repair: A 30-year experience with 960 patients

Current Strategy of Repair of Tetralogy of Fallot in Children and Adults: Emphasis on a New Technique to Create a Monocusp‐Patch for Reconstruction of the Right Ventricular Outflow Tract

[Surgical results of tetralogy of Fallot repair with pulmonary valve preservation techniques]

Pulmonary valve replacement—A 10-year single-center surgical experience in ACHD patients

Effect of Somatostatin in the Syrian Hamster Bearing a Transplantable Islet-Cell Tumor*

The Role of Cardiopulmonary Exercise Testing for Decision Making in Patients with Repaired Tetralogy of Fallot